TY - JOUR
T1 - Prognostic neuroimaging biomarkers of trauma-related psychopathology
T2 - resting-state fMRI shortly after trauma predicts future PTSD and depression symptoms in the AURORA study
AU - Harnett, Nathaniel G.
AU - van Rooij, Sanne J.H.
AU - Ely, Timothy D.
AU - Lebois, Lauren A.M.
AU - Murty, Vishnu P.
AU - Jovanovic, Tanja
AU - Hill, Sarah B.
AU - Dumornay, Nathalie M.
AU - Merker, Julia B.
AU - Bruce, Steve E.
AU - House, Stacey L.
AU - Beaudoin, Francesca L.
AU - An, Xinming
AU - Zeng, Donglin
AU - Neylan, Thomas C.
AU - Clifford, Gari D.
AU - Linnstaedt, Sarah D.
AU - Germine, Laura T.
AU - Bollen, Kenneth A.
AU - Rauch, Scott L.
AU - Lewandowski, Christopher
AU - Hendry, Phyllis L.
AU - Sheikh, Sophia
AU - Storrow, Alan B.
AU - Musey, Paul I.
AU - Haran, John P.
AU - Jones, Christopher W.
AU - Punches, Brittany E.
AU - Swor, Robert A.
AU - McGrath, Meghan E.
AU - Pascual, Jose L.
AU - Seamon, Mark J.
AU - Mohiuddin, Kamran
AU - Chang, Anna M.
AU - Pearson, Claire
AU - Peak, David A.
AU - Domeier, Robert M.
AU - Rathlev, Niels K.
AU - Sanchez, Leon D.
AU - Pietrzak, Robert H.
AU - Joormann, Jutta
AU - Barch, Deanna M.
AU - Pizzagalli, Diego A.
AU - Sheridan, John F.
AU - Harte, Steven E.
AU - Elliott, James M.
AU - Kessler, Ronald C.
AU - Koenen, Karestan C.
AU - Mclean, Samuel
AU - Ressler, Kerry J.
AU - Stevens, Jennifer S.
N1 - Funding Information:
This research was supported by the National Institute of Mental Health K00 MH119603, K01 MH118467, and U01 MH110925, the US Army Medical Research and Material Command, The One Mind Foundation, and The Mayday Fund. DAP has received consulting fees from Akili Interactive Labs, BlackThorn Therapeutics, Boehringer Ingelheim, Posit Science, and Takeda Pharmaceuticals, as well as an honorarium from Alkermes for activities unrelated to the current project. KJR has received consulting income from Alkermes and Takeda, research support from NIH, Genomind and Brainsway, and he is on scientific advisory boards for Janssen and Verily, all of which are unrelated to the present work. RCK has received support for his epidemiological studies from Sanofi Aventis; was a consultant for Datastat, Inc., Sage Pharmaceuticals, and Takeda. CWJ has received funding from Roche Diagnostics, AstraZeneca, Janssen, and Hologic Inc. JME reports support from the National Institutes of Health (NIH) through Grant Numbers R01HD079076 and R03HD094577: Eunice Kennedy Shriver National Institute of Child Health & Human Development; National Center for Medical Rehabilitation Research. SS has received funding from the Florida Medical Malpractice Joint Underwriter’s Association Dr. Alvin E. Smith Safety of Healthcare Services Grant; the NIH/NIA-funded Jacksonville Aging Studies Center (JAX- ASCENT; R33AG05654); and the Florida Blue Foundation. The authors declare no competing interests.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to American College of Neuropsychopharmacology.
PY - 2021/6
Y1 - 2021/6
N2 - Neurobiological markers of future susceptibility to posttraumatic stress disorder (PTSD) may facilitate identification of vulnerable individuals in the early aftermath of trauma. Variability in resting-state networks (RSNs), patterns of intrinsic functional connectivity across the brain, has previously been linked to PTSD, and may thus be informative of PTSD susceptibility. The present data are part of an initial analysis from the AURORA study, a longitudinal, multisite study of adverse neuropsychiatric sequalae. Magnetic resonance imaging (MRI) data from 109 recently (i.e., ~2 weeks) traumatized individuals were collected and PTSD and depression symptoms were assessed at 3 months post trauma. We assessed commonly reported RSNs including the default mode network (DMN), central executive network (CEN), and salience network (SN). We also identified a proposed arousal network (AN) composed of a priori brain regions important for PTSD: the amygdala, hippocampus, mamillary bodies, midbrain, and pons. Primary analyses assessed whether variability in functional connectivity at the 2-week imaging timepoint predicted 3-month PTSD symptom severity. Left dorsolateral prefrontal cortex (DLPFC) to AN connectivity at 2 weeks post trauma was negatively related to 3-month PTSD symptoms. Further, right inferior temporal gyrus (ITG) to DMN connectivity was positively related to 3-month PTSD symptoms. Both DLPFC-AN and ITG-DMN connectivity also predicted depression symptoms at 3 months. Our results suggest that, following trauma exposure, acutely assessed variability in RSN connectivity was associated with PTSD symptom severity approximately two and a half months later. However, these patterns may reflect general susceptibility to posttraumatic dysfunction as the imaging patterns were not linked to specific disorder symptoms, at least in the subacute/early chronic phase. The present data suggest that assessment of RSNs in the early aftermath of trauma may be informative of susceptibility to posttraumatic dysfunction, with future work needed to understand neural markers of long-term (e.g., 12 months post trauma) dysfunction. Furthermore, these findings are consistent with neural models suggesting that decreased top-down cortico-limbic regulation and increased network-mediated fear generalization may contribute to ongoing dysfunction in the aftermath of trauma.
AB - Neurobiological markers of future susceptibility to posttraumatic stress disorder (PTSD) may facilitate identification of vulnerable individuals in the early aftermath of trauma. Variability in resting-state networks (RSNs), patterns of intrinsic functional connectivity across the brain, has previously been linked to PTSD, and may thus be informative of PTSD susceptibility. The present data are part of an initial analysis from the AURORA study, a longitudinal, multisite study of adverse neuropsychiatric sequalae. Magnetic resonance imaging (MRI) data from 109 recently (i.e., ~2 weeks) traumatized individuals were collected and PTSD and depression symptoms were assessed at 3 months post trauma. We assessed commonly reported RSNs including the default mode network (DMN), central executive network (CEN), and salience network (SN). We also identified a proposed arousal network (AN) composed of a priori brain regions important for PTSD: the amygdala, hippocampus, mamillary bodies, midbrain, and pons. Primary analyses assessed whether variability in functional connectivity at the 2-week imaging timepoint predicted 3-month PTSD symptom severity. Left dorsolateral prefrontal cortex (DLPFC) to AN connectivity at 2 weeks post trauma was negatively related to 3-month PTSD symptoms. Further, right inferior temporal gyrus (ITG) to DMN connectivity was positively related to 3-month PTSD symptoms. Both DLPFC-AN and ITG-DMN connectivity also predicted depression symptoms at 3 months. Our results suggest that, following trauma exposure, acutely assessed variability in RSN connectivity was associated with PTSD symptom severity approximately two and a half months later. However, these patterns may reflect general susceptibility to posttraumatic dysfunction as the imaging patterns were not linked to specific disorder symptoms, at least in the subacute/early chronic phase. The present data suggest that assessment of RSNs in the early aftermath of trauma may be informative of susceptibility to posttraumatic dysfunction, with future work needed to understand neural markers of long-term (e.g., 12 months post trauma) dysfunction. Furthermore, these findings are consistent with neural models suggesting that decreased top-down cortico-limbic regulation and increased network-mediated fear generalization may contribute to ongoing dysfunction in the aftermath of trauma.
UR - http://www.scopus.com/inward/record.url?scp=85099832412&partnerID=8YFLogxK
U2 - 10.1038/s41386-020-00946-8
DO - 10.1038/s41386-020-00946-8
M3 - Article
C2 - 33479509
AN - SCOPUS:85099832412
SN - 0893-133X
VL - 46
SP - 1263
EP - 1271
JO - Neuropsychopharmacology
JF - Neuropsychopharmacology
IS - 7
ER -